Sobi has completed issues of class C shares
STOCKHOLM, Aug. 21, 2025 /PRNewswire/ -- The Annual General Meeting of Swedish Orphan Biovitrum AB (publ) (Sobi®) on 8 May 2025 resolved on directed issues of redeemable and convertible class C sha...
How does this capital raise compare to recent financing activities of peer biotech companies, and what could be the market reaction to the repurchase authorization?
What are the terms and pricing of the class C shares, and how might they influence the company's capital structure and cost of capital?
How will the directed issuance of redeemable and convertible class C shares affect Sobi's share dilution and earnings per share?
2 days ago